Novavax to Report Q4 Earnings: Here's What You Can Expect
Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, ...
Medscape6d
Fidaxomicin: A New Macrocyclic, RNA Polymerase-inhibiting Antibiotic for the Treatment of Clostridium difficile Infections
Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...
dermatologyadvisor5d
Hidradenitis Suppurativa Treatment Guidelines Issued for Special Populations
A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...
Medscape4d
Is Disease Activity in IBD a Risk for C difficile Infection?
Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...
Study shows tagatose may combat antibiotic-resistant C. difficile infections
A new UConn study reveals that tagatose, a plant-based sugar alternative, shows promise in mitigating Clostridioides ...
gut.bmj2d
Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation
“C difficile induced TJ disruption may be due to alterations ... SDS is supported by a Research Fellowship Award from the Crohn’s and Colitis Foundation of American. We would like to thank Ms ...